Table 3.
Trial outcomes in Routine F/U patients
| CARDIAC AND NEUROLOGIC MORBIDITY AND MORTALITY (N=192) | P | # OF COMPLICATIONS | ||
|---|---|---|---|---|
|
Low MAP (n=101) |
15.8% |
|
Perioperative |
13 |
| |
|
6 months |
4 |
|
| |
|
Total |
17 |
|
| |
0.022 |
|
||
|
High MAP (n=91) |
5.5% |
|
Perioperative |
4 |
| |
|
6 months |
3 |
|
| |
|
|
Total |
5 |
|
Total Cardiac and neurologic morbidity and mortality |
10.9% |
|
Total |
21 |
|
Neurocognitive Dysfunction Cardiac and Neurologic Morbidity and Mortality at 6 months (n=166) | ||||
| Low MAP |
11.6% |
0.68 |
6 months |
10 |
| High MAP |
13.8% |
|
6 months |
11 |
|
Total |
12.7% |
|
|
21 |
|
Functional Decline at 6 months n=160) | ||||
| Low MAP |
9.4% |
0.38 |
6 months |
8 |
| High MAP |
5.3% |
|
6 months |
4 |
|
Total |
7.5% |
|
|
12 |
|
Combined Trial Outcome (n=192) | ||||
| Low MAP |
31.7% |
0.061 |
|
32 |
| High MAP |
19.8% |
|
|
18 |
| Total | 26.0% | 50 | ||
(Surveillance on 248 participants perioperatively and 187 participants at 6 months).